LearnICU
Visit LearnICU
offered by the Society of Critical Care Medicine
for the following opportunities:
37th Critical Care Congress: The Cutting Edge of Sepsis Therapies Vodcast
-
Daniel Meldrum, MD examines when and why to use beta-blockers in septic shock
-
Sara S. Cheng, MD presents on the use of anticoagulants in sepsis
-
Jeffery S. Vender, MD, FCCM discusses hemodynamic monitoring in sepsis
-
Claudio Ronco, MD assesses the role of hemofiltration in sepsis
-
Jean-Louis Vincent, MD, PhD, FCCM presents an evidence-based approach to sepsis
37th Critical Care Congress: The Cutting Edge of Sepsis Therapies Vodcast
- Jerry J. Zimmerman, MD, PhD, FCCM evaluates the role of steroid use in pediatric sepsis
- Vinay M. Nadkarni, MD, FCCM discusses the approach to tight glycemic control in critically ill children
- Mark R. Rigby, MD, PhD presents the mechanisms and effects of tight glycemic control in children
- Joseph A. Carcillo, MD describes the application of goal-directed therapy to pediatric septic shock
-
Elizabeth A. Farrington, PharmD reviews current information on the use of vassopressin in pediatric septic shock
36th Critical Care Congress: The Cutting Edge of Sepsis Therapies Vodcast
-
Judith Jacobi, PharmD, FCCM reviews the rationale for using various fluid products during the resuscitation of the septic patient, including the use of crystalloids versus colloids versus blood products. Emanuel Rivers, MD, MPH further explains early goal-directed therapy interventions for the patient with sepsis and how early treatment can reduce mortality. Jean-Louis Vincent, MD, PhD, FCCM discusses the results from clinical trials assessing the adequacy of resuscitation in the septic patient. James Russell, MD compares the rationales for vasopresin and norepinephrine in shock.
